TMS for Smoking Cessation

What is Smoking Cessation and How TMS Helps

Tobacco kills more than 480,000 Americans every year. Most smokers know this. About 70% say they want to quit. But only 7-8% of unaided quit attempts last past six months. Even with the best medications, long-term quit rates hover around 25-35%. Quitting is one of those things that sounds simple and isn’t.

The reason is brain chemistry. Nicotine hijacks your reward circuitry, creating deep associations between smoking and pleasure, stress relief, social comfort. Over time, these associations embed themselves in specific brain structures — especially the insula and the prefrontal cortex. The insula sits buried in the lateral sulcus and handles interoception: your ability to sense and interpret internal body states. When you feel a craving, the insula is translating neurochemical signals into that visceral, whole-body pull that makes nicotine addiction feel so physical.

A 2007 study in Science made this dramatically clear: stroke patients who sustained insula damage were able to quit smoking almost effortlessly. Their bodies just “forgot the urge to smoke.” The research question became obvious. If disrupting insula function could eliminate cravings, could brain stimulation do something similar — without the brain damage?

That’s exactly what TMS does. In August 2020, the FDA cleared BrainsWay’s Deep TMS system with the H4 coil for smoking cessation — the first and still the only non-invasive brain stimulation device approved specifically for helping people quit. A non-pharmacological, non-behavioral treatment that directly modulates the brain circuits driving nicotine addiction.

How TMS Works for Smoking Cessation

Brain Regions and the H4 Coil

Standard TMS uses figure-8 coils that stimulate the cortex within about 1.5-2 cm of the scalp. The insula sits 2-3 cm deeper. Out of reach. That’s why BrainsWay built the H4 coil — a specialized deep TMS helmet that generates magnetic fields reaching deeper structures while keeping superficial stimulation at acceptable levels.

The H4 coil delivers bilateral stimulation targeting both left and right lateral prefrontal cortex and — the key part — the bilateral insula simultaneously. Both hemispheres matter here because addiction circuitry isn’t lateralized the way depression circuitry is. Both sides contribute to craving and reward processing.

The Cue-Exposure Protocol

This is what makes smoking cessation TMS unlike any other TMS application. Before the magnetic pulses start, you watch a standardized video — about one minute long — featuring people smoking, cigarette packs, lighters, ashtrays. Familiar imagery designed to trigger a craving.

Why deliberately make you want a cigarette? Because the cue exposure activates your craving circuits — the insula, prefrontal cortex, and anterior cingulate all light up as your brain recognizes the cues and generates a craving response. TMS then hits these circuits while they’re maximally active. The science behind this (state-dependent neuroplasticity) says that modulating a circuit while it’s engaged produces more lasting changes than stimulating it at rest. TMS catches the craving circuits in the act.

Stimulation Parameters

• Frequency: 10 Hz (high-frequency, excitatory) — this sounds counterintuitive for reducing cravings, but the stimulation appears to strengthen prefrontal cognitive control over craving impulses rather than simply suppressing them.
• Intensity: 120% of resting motor threshold.
• Pulses per session: About 1,980 pulses in 33 trains of 60 pulses each, with 15-second intervals between trains.
• Session duration: 18-20 minutes of active stimulation, plus cue exposure.
• Coil: BrainsWay H4 only — no other coil has FDA clearance for this.

The Craving Reduction Mechanism

Several things happen at once. Bilateral insular stimulation modulates the interoceptive signaling that creates the physical sensation of craving. Prefrontal stimulation strengthens the executive control networks that override automatic smoking behavior. And repeated sessions produce lasting neuroplastic changes in insula-prefrontal connectivity, gradually weakening the neural pathways that turn withdrawal signals into conscious cravings and compulsive smoking.

Clinical Evidence and Success Rates

The Pivotal Trial

FDA clearance came from a multicenter, randomized, double-blind, sham-controlled trial published in 2019 by Zangen et al. in JAMA Internal Medicine. 262 participants across the U.S., Israel, and Canada. All smoked at least 10 cigarettes per day with at least one prior failed quit attempt.

Here’s the interesting part: quit rates actually improved from end of treatment to 18 weeks in the TMS group (28% to 33%). That’s unusual. It suggests the neuroplastic changes keep consolidating after treatment ends, making it progressively easier — not harder — to stay quit. Most cessation interventions show the opposite pattern.

How That Compares

• Unaided quit attempts: 3-5% at 6-12 months
• Nicotine replacement (NRT) alone: 15-20% at 6 months
• Varenicline (Chantix): 25-35% at 6 months (the best single drug)
• Bupropion (Wellbutrin/Zyban): 20-25% at 6 months
• Deep TMS: 28-33% at 18 weeks
• NRT + behavioral counseling: 25-30% at 6 months

TMS is competitive with the best medications available. Combined with NRT and counseling — which most clinicians recommend — the overall success rate may be even higher, though large combination trials haven’t been published yet.

Additional Evidence

• Dinur-Klein et al. (2013) in Biological Psychiatry first showed that bilateral Deep TMS plus cue exposure significantly cut cigarette consumption vs. sham.
• Trojak et al. (2015) in Brain Stimulation found that even standard figure-8 TMS targeting the left DLPFC reduced consumption, though the effect was smaller — consistent with the importance of reaching the insula.
• A 2020 fMRI study showed that TMS responders had reduced insula activation in response to smoking cues after treatment. Direct neurobiological evidence for the craving-reduction mechanism.

Who Qualifies for TMS Treatment

Ideal Candidates

• Current daily smoker, at least 10 cigarettes per day
• At least one serious quit attempt using other methods (NRT, medication, counseling) that didn’t work
• Motivated to quit — TMS reduces the neurobiological pull, but it works best alongside genuine commitment and behavioral changes
• Willing to complete the full 18-session course over 6 weeks

Good Candidates with Special Considerations

• Smokers with co-occurring depression or anxiety: You may benefit on two fronts, since the prefrontal stimulation can address mood alongside cravings. Some providers design coordinated protocols.
• Can’t tolerate cessation medications: Varenicline causes nausea, vivid dreams, and mood changes in some people. Bupropion carries seizure risk and is contraindicated in certain conditions. TMS offers a different route.
• Heavy smokers (20+ cigarettes/day): The pivotal trial included heavy smokers, and benefits were seen across smoking levels.

Who May Not Be a Good Candidate

• Metallic implants in or near the head (dental work is fine)
• History of seizure disorders or conditions lowering the seizure threshold
• Currently on medications that significantly lower seizure threshold without medical clearance
• Not genuinely motivated to quit — TMS reduces cravings but doesn’t eliminate the need for commitment and behavioral change

What to Expect During Treatment

Before You Start

Your provider conducts an evaluation: smoking history (years, cigarettes per day, previous quit attempts and methods), medical history for TMS safety, baseline carbon monoxide breath testing, and goal-setting for your quit date — typically planned for week 2 or 3 of treatment.

A Typical Session

1. Check-in (5 minutes): Report on smoking since last session. Brief craving assessment. Possible CO breath test.
2. Cue exposure (1-2 minutes): Watch a video with smoking imagery. Your craving circuits activate. You may feel an increased urge to smoke — expected and intentional.
3. Helmet fitting (2-3 minutes): H4 coil positioned and adjusted. (First session includes motor threshold measurement, adding 10-15 minutes.)
4. Active stimulation (18-20 minutes): Magnetic pulses in 10 Hz trains. You’ll feel tapping or pressure on your scalp. Uncomfortable but tolerable, and it fades after the first few sessions.
5. Done: No recovery. Drive, work, live your life immediately.

Treatment Schedule

18 sessions over 6 weeks, 3 sessions per week. Some clinics offer accelerated daily schedules. Sessions are typically on non-consecutive days to allow neural recovery between treatments.

Setting a Quit Date

Most clinicians recommend targeting your quit date during week 2 or 3, after the initial sessions have started reducing craving intensity. This way you experience the craving reduction before committing to full abstinence — which builds confidence. You are not expected to quit on day one.

Side Effects and Safety

Common Side Effects

• Scalp discomfort during stimulation: About 40-50% of patients. The deep TMS helmet stimulates a broader area, so the sensation is more noticeable. Mostly fades after 3-5 sessions.
• Headache: 15-25% of patients, mild, responsive to acetaminophen or ibuprofen.
• Jaw twitching: The H4 coil can activate facial muscles. Harmless but startling at first.

Rare Side Effects

• Seizure: Less than 0.1% (about 1 in 10,000 sessions). No seizures in the smoking cessation pivotal trial.
• Transient hearing changes: Prevented by wearing the provided earplugs during treatment.

What TMS Doesn’t Cause

Unlike cessation medications, TMS doesn’t cause nausea (a common varenicline complaint), insomnia or vivid dreams, cardiovascular effects, mood disturbances or suicidal ideation, or drug interactions. That clean profile matters a lot if you’ve had bad reactions to cessation meds or take multiple medications for other conditions.

TMS Devices Used for Smoking Cessation

The FDA-Cleared Device

BrainsWay Deep TMS System with H4 Coil: The only TMS device with FDA clearance for smoking cessation. The H4 coil reaches the bilateral insula and lateral prefrontal cortex simultaneously. The system includes the stimulator, H4 coil helmet, positioning system, and integrated cue-exposure software. If a clinic offers smoking cessation TMS, they need this specific device.

Can Other Devices Be Used?

Standard figure-8 coil systems (NeuroStar, MagVenture, etc.) have been studied for smoking cessation, typically targeting the left DLPFC. Some showed modest effects on consumption, but results were weaker than the Deep TMS H4 approach — likely because standard coils can’t reach the insula. Using a figure-8 coil for smoking cessation would be off-label and off-protocol. If a clinic offers this without the BrainsWay H4, ask them to explain their evidence base.

Cost and Insurance Coverage

Typical Costs

A full 18-session course runs $6,000-$10,000 without insurance. Some clinics offer package pricing including evaluation and follow-ups. Individual sessions typically cost $350-$600.

Insurance Coverage Status

Despite FDA clearance, insurance coverage remains inconsistent as of 2026:

• Most private insurers don’t have formal coverage policies yet. Some are developing criteria, but it’s far from universal.
• Medicare doesn’t currently cover TMS for smoking cessation nationally, though regional decisions may differ.
• Some employer plans with strong smoking cessation benefits may cover it, particularly if you’ve documented failure of other covered treatments.

Why Coverage Is Limited Despite FDA Clearance

Insurance decisions weigh more than FDA status: cost-effectiveness data, published evidence volume, formal clinical guidelines. The evidence base is strong enough for clearance but still growing. As more long-term and cost-effectiveness data comes in, coverage should expand.

Making It More Affordable

• Package pricing: Many clinics discount when you pay upfront for the full course.
• Medical financing: CareCredit, Prosper Healthcare Lending, and others offer payment plans with promotional rates.
• Clinical trials: Some academic centers run smoking cessation TMS studies at reduced or no cost.
• Combo approach: If you also have depression, some providers can structure treatment to address both, potentially getting insurance to cover TMS under the depression diagnosis while smoking cessation benefits follow.
• Do the math: A pack-a-day smoker in a high-tax state spends $3,000-$5,000 a year on cigarettes, plus incalculable healthcare costs down the line. A one-time TMS investment that works can pay for itself in 1-3 years.

Finding a TMS Provider for Smoking Cessation

What to Look For

Not every TMS clinic can offer smoking cessation — it requires the specific BrainsWay H4 coil. When searching:

1. Confirm they have the BrainsWay Deep TMS with H4 coil: Non-negotiable. Ask specifically — some BrainsWay systems use H1 coils (depression) and may not have the H4.
2. Ask about cue-exposure: The provider should describe the standardized video protocol before each session. It’s a core component, not optional.
3. Inquire about cessation support: The best outcomes combine TMS with behavioral counseling. Does the clinic provide it? Do they support NRT use during treatment? Is there a structured quit plan?
4. Ask about follow-up and relapse prevention: What happens after the 18 sessions? Maintenance options? Ongoing support during the critical first months?
5. Check credentials: The treating provider should be trained in both TMS administration and addiction medicine or smoking cessation.

Combining TMS with Other Quit Strategies

TMS works best as part of a broader plan. Most clinicians recommend:

• Nicotine replacement (NRT): Patches, gum, or lozenges alongside TMS. NRT handles physical withdrawal while TMS targets craving circuits — complementary mechanisms.
• Behavioral counseling: CBT strategies for managing triggers, building new habits, and preventing relapse. Significantly boosts long-term success when combined with any biological treatment.
• Quit lines and support groups: 1-800-QUIT-NOW and local groups provide ongoing support through the hardest weeks and months.
• Mindfulness: Some evidence suggests mindfulness training and TMS may have synergistic effects on craving, since both engage prefrontal regulatory circuits.

Frequently Asked Questions

How quickly does TMS reduce cravings?

Most people notice reduced craving intensity within the first 1-2 weeks (3-6 sessions). It’s gradual, not sudden — you may find yourself thinking about cigarettes less, or the post-meal urge feels less overwhelming. By weeks 3-4, many people report cravings are manageable enough to stay quit with reasonable effort.

Do I need to quit before starting TMS?

No. Start TMS while still smoking. Let the treatment reduce craving intensity over the first 2-3 weeks, then set a quit date when the cravings feel manageable. This staged approach is less intimidating than going cold turkey and takes advantage of cumulative neuroplastic effects.

Can TMS help with vaping or other nicotine products?

The FDA clearance and pivotal trial specifically addressed cigarettes. No published trial data exists for vaping, e-cigarettes, or smokeless tobacco. But since all nicotine products involve the same brain circuits, some clinicians offer TMS off-label for these. The evidence is limited — discuss it openly with your provider.

What if I relapse after finishing TMS?

Relapse is a recognized part of addiction recovery, not a failure. You can do a second course. Some people benefit from shorter “booster” courses of 6-12 sessions rather than repeating all 18. Your provider can assess whether full retreatment or maintenance makes more sense based on when and why the relapse happened.

Can TMS be combined with varenicline or bupropion?

Usually, yes. No contraindication with varenicline. Bupropion needs more caution because it lowers seizure threshold, but it’s not an absolute contraindication — your provider will assess risk based on your dose and individual factors. Some clinicians think the combination may produce additive benefits, though large formal trials haven’t been done.